Malaria vaccine, Mosquirix, gets European nod

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2015

Singapore: GlaxoSmithKline has received a positive opinion for its Malaria vaccine candidate from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...Read more

Novavax's Ebola vaccine shows promise in human trial

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2015

Singapore: US-based Novavax recently announced that its experimental candidate vaccine for Ebola showed promise in early stage human clinical trial. The vaccine induced a substantial immune...Read more

No more needles, no more pain!

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2015

Singapore: Vaccination will no longer be a painful process as researchers from Japan's Osaka University have developed a new technique that can deliver vaccines without needles. The new met...Read more

Shanghai BravoBio wins BioSpectrum award for role in China vaccine industry

Vaccines |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

Chinese vaccine development companies are raising the bar to meet international standards. However, access to foreign markets remains a challenge. Shanghai BravoBio, which has a strong and ...Read more

WHO and World Food Program join forces to reach zero Ebola cases

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2015

Singapore: WHO and United Nations World Food Program (WFP) have come together to build logistics strength for Ebola-affected countries of Guinea, Liberia and Sierra Leone to help get the cu...Read more

FDA nod for Sanofi quadrivalent flu vaccine

Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2013

Singapore: The US FDA has approved Sanofi Pasteur supplemental biologics license application (sBLA) for its four-strain influenza vaccine, Fluzone Quadrivalent, which is the newest addition...Read more

Vaccine for AIDS in ten years: Bill Gates

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2015

Singapore: With no cure or vaccine available for AIDS, that is spreading across the globe like a wide epidemic, billionaire philanthropist Mr Bill Gates, who spends millions of dollars on A...Read more

AIDS 2014: Slash in fund jolts HIV research

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2014

Singapore: Investment in HIV prevention research has declined posing a challenge to the pipeline of HIV prevention products in various stages of development and implementation of an effecti...Read more

Novartis completes divestiture of influenza vaccines business

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 18 Aug, 2015

Singapore: Novartis has announced that it has completed the divestiture of its influenza vaccine unit to CSL Limited. This marks the end of a series of transactions previously announced and...Read more

J&J's HIV vaccine to begin human trials

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2015

Singapore: Bringing new hope to millions of people worldwide, the experimental HIV vaccine developed by Johnson & Johnson has shown promise in early clinical trials. As per reports the ...Read more

Agilent, A*Star, French univ sign biologics MoU

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 27 May, 2013

Singapore: Agilent Technologies, Glyco-MEV laboratory at the University of Rouen, France, and Bioprocessing Technology Institute (BTI) at the Agency for Science, Technology and Research (A*...Read more

Stanford Univ reverse vaccine to treat diabetes

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 28 Jun, 2013

Singapore: Scientists at Stanford University, US, and Leiden University Medical Center in the Netherlands, have tested a 'reverse vaccine' that dampens the immune systems of people with typ...Read more

EU approves Merck's Keytruda for melanoma

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2015

Merck has announced that the European Commission has approved KEYTRUDA (pembrolizumab), its anti-PD-1 therapy, for the treatment of advanced (unresectable or metastatic) melanoma in adults...Read more

Astellas, ClearPath to enter strategic partnership

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jan, 2014

Singapore: Astellas Pharma and ClearPath Development Company have announced a strategic partnership to form a portfolio of development companies focused on vaccines targeting infectious dis...Read more

Sanofi gears up to introduce dengue vaccine

Vaccines |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2014

Healthcare stakeholders are keeping high hopes with the successful results of Sanofi Pasteur's Phase III trial of dengue vaccine completed this year and a vaccine may be available soon. The...Read more

India's vaccine future looks bright despite hurdles

Vaccines |  Analysis | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

The Indian vaccine industry has been in the past few years following close on the footsteps of the Indian pharma sector. The vaccine industry has been making concerted efforts to develop va...Read more

HIV vaccine dream can now be a reality

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2013

Singapore: Scientists at Vaccine and Gene Therapy Institute of Florida (VGTI), US, a nonprofit immunological research institute, showed that previously unidentified dysfunction in follicula...Read more

Imaxio starts human trials with re-engineered TB antigen

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2013

Singapore: Vaccine firm Imaxio's proprietary pro-immunogenic technology, IMX313, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The tri...Read more